Home > Media Centre > Press Releases
Press releases
AM-Pharma to Participate in Upcoming Jefferies Healthcare Conference
Utrecht, The Netherlands, June 6, 2022 – AM-Pharma B.V., an…
400 PATIENTS HAVE BEEN ENROLLED IN AM-PHARMA’s PIVOTAL PHASE 3 STUDY OF ILOFOTASE ALFA FOR THE TREATMENT OF SEPSIS-ASSOCIATED ACUTE KIDNEY INJURY
Decision from the first pre-specified futility analysis at…
AM-Pharma to Participate in SVB Leerink Biopharma Private Company Connect
Utrecht, The Netherlands, March 22, 2022 – AM-Pharma B.V.,…
AM-PHARMA ANNOUNCES TWO PRESENTATIONS AT THE 27TH INTERNATIONAL CONFERENCE ON ADVANCES IN CRITICAL CARE NEPHROLOGY
The lead investigator will present an overview of AM-Pharma’s…
AM-Pharma to Participate in Upcoming Investor and Scientific Conferences
UTRECHT, The Netherlands - AM-Pharma B.V., an emerging leader…